This Article Full Text Full Text (PDF) All Versions of this Article: 146/12/5380    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hu, T. Articles by Michael, L. F. Search for Related Content PubMed PubMed Citation Articles by Hu, T. Articles by Michael, L. F.

Hepatic Peroxisomal Fatty Acid ß-Oxidation Is Regulated by Liver X Receptor

Lilly Research Laboratories, Departments of Cardiovascular Research (T.H., P.F., J.V.F., M.C., G.C., P.E., L.F.M.), Endocrinology (A.S., M.D.M.), Toxicology (H.G., T.R.), Integrative Biology (S.L.), Eli Lilly & Co., Indianapolis, Indiana 46285

Address all correspondence and requests for reprints to: Dr. Laura F. Michael, Eli Lilly & Co., Cardiovascular Research, DC 0520, Indianapolis, Indiana 46285. E-mail: laura_michael{at}lilly.com.

Peroxisomes are the exclusive site for the ß-oxidation of very-long-chain fatty acids of more than 20 carbons in length (VLCFAs). Although the bulk of dietary long-chain fatty acids are oxidized in the mitochondria, VLCFAs cannot be catabolized in mitochondria and must be shortened first by peroxisomal ß-oxidation. The regulation of peroxisomal, mitochondrial, and microsomal fatty acid oxidation systems in liver is mediated principally by peroxisome proliferator-activated receptor (PPAR). In this study we provide evidence that the liver X receptor (LXR) regulates the expression of the genetic program for peroxisomal ß-oxidation in liver. The genes encoding the three enzymes of the classic peroxisomal ß-oxidation cycle, acyl-coenzyme A (acyl-CoA) oxidase, enoyl-CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase, and 3-ketoacyl-CoA thiolase, are activated by the LXR ligand, T0901317. Accordingly, administration of T0901317 in mice promoted a dose-dependent and greater than 2-fold increase in the rate of peroxisomal ß-oxidation in the liver. The LXR effect is independent of PPAR, because T0901317-induced peroxisomal ß-oxidation in the liver of PPAR-null mice. Interestingly, T0901317-induced peroxisomal ß-oxidation is dependent on the LXR isoform, but not the LXRß isoform. We propose that induction of peroxisomal ß-oxidation by LXR agonists may serve as a counterregulatory mechanism for responding to the hypertriglyceridemia and liver steatosis that is promoted by potent LXR agonists in vivo; however, additional studies are warranted.

This article has been cited by other articles:

				G. Musso, R. Gambino, F. De Michieli, G. Biroli, A. Premoli, G. Pagano, S. Bo, M. Durazzo, and M. Cassader Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake Am. J. Clinical Nutrition, September 1, 2007; 86(3): 661 - 671. [Abstract] [Full Text] [PDF]